News

Select Year

• October 9, 2025

  FYR Integrates CIQ Fuzzball to Scale AI-Enabled Multiomic Platform and Accelerate Breakthroughs in Precision Medicine

• September 24, 2025

  FYR Closes $8 Million Financing to Advance Blood-Based Biomarkers Across Oncology and Neuroscience

• April 29, 2025

  FYR Enters Know-How Agreement with Mayo Clinic to Collaborate on Blood-Based Biomarker Solutions for Parkinson’s Disease

• January 9, 2025

  FYR Appoints Chris Howlett to its Board of Directors

• November 22, 2024

  Poster | SNO 2024 | Utilization of Tumor-derived Extracellular Vesicles for Patient Stratification and Biomarker Discovery